Curiel DT - Search Results

1

In vivo imaging of adenovirus transduction and enhanced therapeutic efficacy of combination therapy with conditionally replicating adenovirus and adenovirus-p27.

Lee CT, Lee YJ, Kwon SY, Lee J, Kim KI, Park KH, Kang JH, Yoo CG, Kim YW, Han SK, Chung JK, Shim YS, Curiel DT, Carbone DP. Lee CT, et al. Among authors: curiel dt. Cancer Res. 2006 Jan 1;66(1):372-7. doi: 10.1158/0008-5472.CAN-05-1515. Cancer Res. 2006. PMID: 16397251

2

Overexpression of adenovirus-encoded transgenes from the cytomegalovirus immediate early promoter in irradiated tumor cells.

Tang DC, Jennelle RS, Shi Z, Garver RI Jr, Carbone DP, Loya F, Chang CH, Curiel DT. Tang DC, et al. Among authors: curiel dt. Hum Gene Ther. 1997 Nov 20;8(17):2117-24. doi: 10.1089/hum.1997.8.17-2117. Hum Gene Ther. 1997. PMID: 9414259

3

Interleukin-6 modulated conditionally replicative adenovirus as an antitumor/cytotoxic agent for cancer therapy.

Rancourt C, Piché A, Gomez-Navarro J, Wang M, Alvarez RD, Siegal GP, Fuller GM, Jones SA, Curiel DT. Rancourt C, et al. Among authors: curiel dt. Clin Cancer Res. 1999 Jan;5(1):43-50. Clin Cancer Res. 1999. PMID: 9918201

4

The development of conditionally replicative adenoviruses for cancer therapy.

Curiel DT. Curiel DT. Clin Cancer Res. 2000 Sep;6(9):3395-9. Clin Cancer Res. 2000. PMID: 10999720 Review.

5

A conditionally replicative adenovirus with enhanced infectivity shows improved oncolytic potency.

Suzuki K, Fueyo J, Krasnykh V, Reynolds PN, Curiel DT, Alemany R. Suzuki K, et al. Among authors: curiel dt. Clin Cancer Res. 2001 Jan;7(1):120-6. Clin Cancer Res. 2001. PMID: 11205899

6

Efficient oncolysis by a replicating adenovirus (ad) in vivo is critically dependent on tumor expression of primary ad receptors.

Douglas JT, Kim M, Sumerel LA, Carey DE, Curiel DT. Douglas JT, et al. Among authors: curiel dt. Cancer Res. 2001 Feb 1;61(3):813-7. Cancer Res. 2001. PMID: 11221860

7

Fiber knob modifications overcome low, heterogeneous expression of the coxsackievirus-adenovirus receptor that limits adenovirus gene transfer and oncolysis for human rhabdomyosarcoma cells.

Cripe TP, Dunphy EJ, Holub AD, Saini A, Vasi NH, Mahller YY, Collins MH, Snyder JD, Krasnykh V, Curiel DT, Wickham TJ, DeGregori J, Bergelson JM, Currier MA. Cripe TP, et al. Among authors: curiel dt. Cancer Res. 2001 Apr 1;61(7):2953-60. Cancer Res. 2001. PMID: 11306473

8

Targeting oncolytic adenoviral agents to the epidermal growth factor pathway with a secretory fusion molecule.

Hemminki A, Dmitriev I, Liu B, Desmond RA, Alemany R, Curiel DT. Hemminki A, et al. Among authors: curiel dt. Cancer Res. 2001 Sep 1;61(17):6377-81. Cancer Res. 2001. PMID: 11522629

9

A midkine promoter-based conditionally replicative adenovirus for treatment of pediatric solid tumors and bone marrow tumor purging.

Adachi Y, Reynolds PN, Yamamoto M, Wang M, Takayama K, Matsubara S, Muramatsu T, Curiel DT. Adachi Y, et al. Among authors: curiel dt. Cancer Res. 2001 Nov 1;61(21):7882-8. Cancer Res. 2001. PMID: 11691808

10

Heat shock and heat shock protein 70i enhance the oncolytic effect of replicative adenovirus.

Haviv YS, Blackwell JL, Li H, Wang M, Lei X, Curiel DT. Haviv YS, et al. Among authors: curiel dt. Cancer Res. 2001 Dec 1;61(23):8361-5. Cancer Res. 2001. PMID: 11731408

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

685 results

Search Page

Filters